Modulating the Microbiome for Crohn's Disease Treatment.

Gowen, Rachael; Gamal, Ahmed; Di Martino, Luca; McCormick, Thomas S; Ghannoum, Mahmoud A

Gowen, Rachael; Gamal, Ahmed; Di Martino, Luca; McCormick, Thomas S; Ghannoum, Mahmoud A.

Afiliação

Gowen R; Department of Dermatology, Case Western Reserve University, Cleveland, Ohio; University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Gamal A; Department of Dermatology, Case Western Reserve University, Cleveland, Ohio; University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Di Martino L; University Hospitals Cleveland Medical Center, Cleveland, Ohio; Department of Medicine, Case Western Reserve University, Cleveland, Ohio; Case Digestive Health Research Institute, Case Western Reserve University, Cleveland Ohio.
McCormick TS; Department of Dermatology, Case Western Reserve University, Cleveland, Ohio; University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Ghannoum MA; Department of Dermatology, Case Western Reserve University, Cleveland, Ohio; University Hospitals Cleveland Medical Center, Cleveland, Ohio. Electronic address: mag3@case.edu.

Gastroenterology ; 164(5): 828-840, 2023 04.

Article em En | MEDLINE | ID: mdl-36702360

Assuntos

Doença de Crohn; Microbioma Gastrointestinal; Microbiota; Probióticos; Humanos; Doença de Crohn/tratamento farmacológico; Probióticos/uso terapêutico; Prebióticos

Palavras-chave

Biotherapeutics; Crohn's Disease; Microbiome; Nutritional Supplements; Targeting the Microbiome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Probióticos / Microbiota / Microbioma Gastrointestinal Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google